In APP/PS1 mice (APPswe/PSEN1dE9 transgenic mice model of AD), transcriptome analysis identified the enriched ACSL4 (Yan et al., 2022), which can be inhibited by tetrahydroxy stilbene glycoside (TSG) (Gao et al., 2021). Here, ACSL4 is linked to Alzheimer disease.